MANAGED ACCOUNT ADVISORS LLC - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 167 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 0.84 and the average weighting 0.3%.

Quarter-by-quarter ownership
MANAGED ACCOUNT ADVISORS LLC ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2015$4,550,000
+17400.0%
267,965
+12451.1%
0.00%
Q1 2015$26,000
+52.9%
2,135
+3.2%
0.00%
Q4 2014$17,000
-15.0%
2,069
-11.9%
0.00%
Q3 2014$20,000
-31.0%
2,348
-10.8%
0.00%
Q2 2014$29,000
+16.0%
2,633
-6.4%
0.00%
Q1 2014$25,000
+19.0%
2,812
+1.8%
0.00%
Q4 2013$21,0002,7630.00%
Other shareholders
SUPERNUS PHARMACEUTICALS INC shareholders Q2 2015
NameSharesValueWeighting ↓
NEA Management Company, LLC 7,641,250$107,207,0007.06%
HealthInvest Partners AB 782,746$10,982,0006.50%
KOPP INVESTMENT ADVISORS LLC 729,960$10,241,0005.51%
Murphy Michael R 1,028,304$14,427,0004.96%
Opaleye Management Inc. 460,000$6,454,0003.18%
ASHFORD CAPITAL MANAGEMENT INC 511,244$7,173,0001.68%
Bruce & Co., Inc. 394,581$5,535,0001.42%
AlphaOne Investment Services, LLC 235,065$3,297,0001.40%
Ranger Investment Management 1,560,453$21,893,0001.23%
NORTHPOINTE CAPITAL LLC 584,753$8,204,0001.07%
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders